General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wolff HA et al. – The data affirm that NPC in adults are curable by primary radio(chemo)therapy. Furthermore, the data indicate that adjuvant interferon–beta application in undifferentiated NPC in adults is feasible and shows promising results. Further prospective clinical trials are needed to finally establish adjuvant interferon beta in curative treatment of adult NPC.

Related Articles

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
European Archives of Oto-Rhino-Laryngology, 10/14/09    Relevance Score: 68%

Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review
The Journal of Laryngology & Otology, 10/06/09    Relevance Score: 68%

Horner Syndrome as a Presenting Sign of Nasopharyngeal Carcinoma
Ophthalmic Plastic and Reconstructive Surgery, 10/07/09    Relevance Score: 67%

Widespread expression of prostate apoptosis response-4 in nasopharyngeal carcinoma
Head & Neck, 11/13/09    Relevance Score: 66%

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Investigational New Drugs, 10/08/09    Relevance Score: 66%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address